FORVIS Wealth Advisors LLC Increases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

FORVIS Wealth Advisors LLC boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,051 shares of the pharmacy operator’s stock after acquiring an additional 11,148 shares during the period. FORVIS Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,411,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of WBA. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $26,000. Pineridge Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Venturi Wealth Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter worth $30,000. Finally, Quest Partners LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at $30,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 4.1 %

Shares of NASDAQ WBA traded down $0.47 during trading hours on Thursday, hitting $11.10. The company’s stock had a trading volume of 26,845,517 shares, compared to its average volume of 20,813,700. Walgreens Boots Alliance, Inc. has a 12 month low of $11.10 and a 12 month high of $31.32. The stock has a market cap of $9.58 billion, a price-to-earnings ratio of -1.65, a P/E/G ratio of 0.81 and a beta of 0.72. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The business has a 50-day simple moving average of $16.10 and a 200-day simple moving average of $19.89.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The business had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.00 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were issued a $0.25 dividend. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 9.01%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.84%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on WBA shares. Deutsche Bank Aktiengesellschaft cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. UBS Group cut their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Monday. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $17.71.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.